Can sacubitril/valsartan become the promising drug to delay the progression of chronic kidney disease?

被引：2
作者：
Chen, Yang [1 ,2 ,3 ,4 ]
Guo, Lu-Ying [1 ,2 ,3 ,4 ]
Zhao, Ling-Fei [1 ,2 ,3 ,4 ]
Ma, Yan-Hong [1 ,2 ,3 ,4 ]
Zhu, Xue-Ling [5 ,6 ,7 ]
Xu, Ying [1 ,2 ,3 ,4 ]
Chen, Jiang-Hua [1 ,2 ,3 ,4 ]
机构：
[1] Zhejiang Univ, Affiliated Hosp 1, Kidney Dis Ctr, Sch Med, Hangzhou, Zhejiang, Peoples R China
[2] Adm Tradit Chinese Med, Grade Lab Natl State 3, Hangzhou, Zhejiang, Peoples R China
[3] Key Lab Kidney Dis Prevent & Control Technol, Hangzhou, Zhejiang, Peoples R China
[4] Zhejiang Univ, Inst Nephrol, Natl Key Clin Dept Kidney Dis, Hangzhou, Zhejiang, Peoples R China
[5] State Key Lab Diag & Treatment Infect Dis, Hangzhou, Zhejiang, Peoples R China
[6] Zhejiang Univ, Affiliated Hosp 1, Natl Clin Res Ctr Infect Dis, Sch Med, Hangzhou, Zhejiang, Peoples R China
[7] Zhejiang Univ, Affiliated Hosp 1, Collaborat Innovat Ctr Diag & Treatment Infect Di, Sch Med, Hangzhou, Zhejiang, Peoples R China
来源：
JOURNAL OF GERIATRIC CARDIOLOGY | 2020年 / 17卷 / 12期
关键词：
Cardiovascular disease; Chronic kidney disease; Kidney function; Sacubitril/valsartan; ANGIOTENSIN-NEPRILYSIN INHIBITION; HEART-FAILURE; CARDIOVASCULAR-DISEASE; ASSOCIATION; IRBESARTAN; LCZ696; EPIDEMIOLOGY; MANAGEMENT; MECHANISMS; ENALAPRIL;
D O I：
10.11909/j.issn.1671-5411.2020.12.002
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Chronic kidney disease (CKD) often coexists with or is a complication of cardiovascular disease. Previous studies have shown that CKD increases the risk of cardiovascular death and all-cause death and was considered to be a risk equivalent of coronary heart disease.[1,2] Adjusted for con-founders, decreased glomerular filtration rate (GFR) and increased albuminuria are both independent risk factors for cardiovascular events.[3,4] The risk for cardiovascular death linearly increases with the decline of GFR in a certain range (< 70 mL/min per 1.73 m2) and the increase of albuminuria without a threshold effect. © 2020 JGC All rights reserved; www.jgc301.com
引用
收藏
页码：782 / 786
页数：5
相关论文
共 28 条
[1]   A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure [J].
Cohn, JN ;
Tognoni, G .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (23) :1667-1675
[2]  
Coronel F, 2008, NEFROLOGIA, V28, P56
[3]   Irbesartan - A review of its use in hypertension and in the management of diabetic nephropathy [J].
Croom, KF ;
Curran, MP ;
Goa, KL ;
Perry, CM .
DRUGS, 2004, 64 (09) :999-1028
[4]   Renal Effects and Associated Outcomes During Angiotensin-Neprilysin Inhibition in Heart Failure [J].
Damman, Kevin ;
Gori, Mauro ;
Claggett, Brian ;
Jhund, Pardeep S. ;
Senni, Michele ;
Lefkowitz, Martin P. ;
Prescott, Margaret F. ;
Shi, Victor C. ;
Rouleau, Jean L. ;
Swedberg, Karl ;
Zile, Michael R. ;
Packer, Milton ;
Desai, Akshay S. ;
Solomon, Scott D. ;
McMurray, John J., V .
JACC-HEART FAILURE, 2018, 6 (06) :489-498
[5]   Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention [J].
Gansevoort, Ron T. ;
Correa-Rotter, Ricardo ;
Hemmelgarn, Brenda R. ;
Jafar, Tazeen H. ;
Heerspink, Hiddo J. Lambers ;
Mann, Johannes F. ;
Matsushita, Kunihiro ;
Wen, Chi Pang .
LANCET, 2013, 382 (9889) :339-352
[6]   Effects of Sacubitril/Valsartan Versus Irbesartan in Patients With Chronic Kidney Disease: A Randomized Double-Blind Trial [J].
Haynes, Richard ;
Judge, Parminder K. ;
Staplin, Natalie ;
Herrington, William G. ;
Storey, Benjamin C. ;
Bethel, Angelyn ;
Bowman, Louise ;
Brunskill, Nigel ;
Cockwell, Paul ;
Hill, Michael ;
Kalra, Philip A. ;
McMurray, John J. V. ;
Taal, Maarten ;
Wheeler, David C. ;
Landray, Martin J. ;
Baigent, Colin .
CIRCULATION, 2018, 138 (15) :1505-1514
[7]  
Jing WH, 2017, AM J TRANSL RES, V9, P5473
[8]   Neutral endopeptidase inhibition and the natriuretic peptide system: an evolving strategy in cardiovascular therapeutics [J].
Mangiafico, Sarah ;
Costello-Boerrigter, Lisa C. ;
Andersen, Ingrid A. ;
Cataliotti, Alessandro ;
Burnett, John C., Jr. .
EUROPEAN HEART JOURNAL, 2013, 34 (12) :886-893
[9]   Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis [J].
Matsushita, Kunihiro ;
van der Velde, Marije ;
Astor, Brad C. ;
Woodward, Mark ;
Levey, Andrew S. ;
de Jong, Paul E. ;
Coresh, Josef ;
Gansevoort, Ron T. .
LANCET, 2010, 375 (9731) :2073-2081
[10]   Angiotensin-Neprilysin Inhibition and Renal Outcomes in Heart Failure With Preserved Ejection Fraction [J].
Mc Causland, Finnian R. ;
Lefkowitz, Martin P. ;
Claggett, Brian ;
Anavekar, Nagesh S. ;
Senni, Michele ;
Gori, Mauro ;
Jhund, Pardeep S. ;
McGrath, Martina M. ;
Packer, Milton ;
Shi, Victor ;
Van Veldhuisen, Dirk J. ;
Zannad, Faiez ;
Comin-Colet, Josep ;
Pfeffer, Marc A. ;
McMurray, John J. V. ;
Solomon, Scott D. .
CIRCULATION, 2020, 142 (13) :1236-1245
123